PCDHGC3
Protocadherin gamma-C3
Also known as: PC-43, PC43, PCDGK_HUMAN, PCDH-GAMMA-C3, PCDH2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UN70
- Gene
- PCDHGC3
- Ensembl
- ENSG00000240184
- Chromosome
- 5
- Canonical length
- 934 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene is a member of the protocadherin gamma gene cluster, one of three related clusters tandemly linked on chromosome five. These gene clusters have an immunoglobulin-like organization, suggesting that a novel mechanism may be involved in their regulation and expression. The gamma gene cluster includes 22 genes divided into 3 subfamilies. Subfamily A contains 12 genes, subfamily B contains 7 genes and 2 pseudogenes, and the more distantly related subfamily C contains 3 genes. The tandem array of 22 large, variable region exons are followed by a constant region, containing 3 exons shared by all genes in the cluster. Each variable region exon encodes the extracellular region, which includes 6 cadherin ectodomains and a transmembrane region. The constant region exons encode the common cytoplasmic region. These neural cadherin-like cell adhesion proteins most likely play a critical role in the establishment and function of specific cell-cell connections in the brain. Alternative splicing has been described for the gamma cluster genes. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
934 residues, UniProt reviewed canonical sequence.
>Q9UN70|PCDHGC3
1 MVPEAWRSGL VSTGRVVGVL LLLGALNKAS TVIHYEIPEE REKGFAVGNV VANLGLDLGS
61 LSARRFRVVS GASRRFFEVN RETGEMFVND RLDREELCGT LPSCTVTLEL VVENPLELFS
121 VEVVIQDIND NNPAFPTQEM KLEISEAVAP GTRFPLESAH DPDVGSNSLQ TYELSRNEYF
181 ALRVQTREDS TKYAELVLER ALDREREPSL QLVLTALDGG TPALSASLPI HIKVLDANDN
241 APVFNQSLYR ARVLEDAPSG TRVVQVLATD LDEGPNGEII YSFGSHNRAG VRQLFALDLV
301 TGMLTIKGRL DFEDTKLHEI YIQAKDKGAN PEGAHCKVLV EVVDVNDNAP EITVTSVYSP
361 VPEDAPLGTV IALLSVTDLD AGENGLVTCE VPPGLPFSLT SSLKNYFTLK TSADLDRETV
421 PEYNLSITAR DAGTPSLSAL TIVRVQVSDI NDNPPQSSQS SYDVYIEENN LPGAPILNLS
481 VWDPDAPQNA RLSFFLLEQG AETGLVGRYF TINRDNGIVS SLVPLDYEDR REFELTAHIS
541 DGGTPVLATN ISVNIFVTDR NDNAPQVLYP RPGGSSVEML PRGTSAGHLV SRVVGWDADA
601 GHNAWLSYSL LGSPNQSLFA IGLHTGQIST ARPVQDTDSP RQTLTVLIKD NGEPSLSTTA
661 TLTVSVTEDS PEARAEFPSG SAPREQKKNL TFYLLLSLIL VSVGFVVTVF GVIIFKVYKW
721 KQSRDLYRAP VSSLYRTPGP SLHADAVRGG LMSPHLYHQV YLTTDSRRSD PLLKKPGAAS
781 PLASRQNTLR SCDPVFYRQV LGAESAPPGQ QAPPNTDWRF SQAQRPGTSG SQNGDDTGTW
841 PNNQFDTEML QAMILASASE AADGSSTLGG GAGTMGLSAR YGPQFTLQHV PDYRQNVYIP
901 GSNATLTNAA GKRDGKAPAG GNGNKKKSGK KEKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCDHGC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 360 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 360 nTPM
- basal ganglia: 341 nTPM
- cerebral cortex: 299 nTPM
- hippocampal formation: 287 nTPM
- midbrain: 229 nTPM
- hypothalamus: 203 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 446 nCPM
- astrocytes: 217 nCPM
- bergmann glia: 177 nCPM
- ependymal cells: 95 nCPM
- brain inhibitory neurons: 72 nCPM
- brain excitatory neurons: 62 nCPM
Immune cell
- plasmacytoid DC: 15 nTPM
- memory B-cell: 0.6 nTPM
- naive B-cell: 0.2 nTPM
- myeloid DC: 0.1 nTPM
- naive CD4 T-cell: 0.1 nTPM
- total PBMC: 0.1 nTPM
Brain region
- thalamus: 248 nTPM
- amygdala: 214 nTPM
- midbrain: 195 nTPM
- basal ganglia: 191 nTPM
- medulla oblongata: 186 nTPM
- cerebral cortex: 185 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 1.41
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
- cell adhesion
- homophilic cell adhesion via plasma membrane adhesion molecules
- negative regulation of neuron apoptotic process
- nervous system development
- synapse organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cadherin-like
- Cadherin, N-terminal
- Cadherin-like superfamily
- Cadherin conserved site
- Cadherin, C-terminal catenin-binding domain
- Cadherin, cytoplasmic C-terminal domain
- Protocadherin/Cadherin-related Cell Adhesion
- Cadherin domain
- Cadherin-like
- Cadherin C-terminal cytoplasmic tail, catenin-binding region
- Cadherin cytoplasmic C-terminal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCDHGC3 as an antibody target. Whether an autoantibody or antibody against PCDHGC3 could matter depends on whether native PCDHGC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCDHGC3 is annotated at the cell surface, where native PCDHGC3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PCDHGC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...